DoGusign Envelope ID.. 198F6FAA-6588485B-9B8&88B6FFC7101D Charity wlstration number 1181776 (England and Wales) THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO LEGAL AND ADMINISTRATIVE INFORMATION Trustees C W Kinder M Stewart J Talks R Pilling M Parul8kar Prol M S Sagoo S de Silva Charbty numbor (England and Wal•sl 1181776 Inde￿ndent •xamln•r Rob Ribchesler FCA MA Finthale House Belmont Business Park Durh8m DH1 1TW DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO CONTENTS Page Trustees. report Independent exarninerfs report Statement of financial activities Balance sheet Notes to Ihe finan￿al statements 9-15 DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO TRUSTEES. REPORT FOR THE YEAR ENDED 31 DECEMBER 2024 The trLJSt88s present th8ir report with the financi81 statem8nts of the charity for the year ended 31 D&c8mb8r 2024. The trustees have adopted the provisions of AcrA)unting and Reporting by Ch8rib"es'. Statement of Recommended Practice applicable to charities pieparing their accounts in acc()rdance wth the Finanaal Repor￿n9 Standard applicable in the UK and Rewblic ol Irdand IFRS 1021 leffects.ve 1 January 20191. The financial ststements have been p￿pa￿d in accordance wth the accounting poliaes set out in note 1 to the financial statements and comply with the Charivs governing document. the Charities Act 2011, FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of I￿land. and the Charities SORP "Accounting and Reporting by Charities.. Ststement of Recommended Practice applicable to charities preparing their account5 in accordance wth the Financial Repor￿ng Standard applicable in th8 UK and Republic of Ireland IFRS 1021" Oblèctlv•s and actlvltlo$ Objectives and aims The objects ol the CIO Ithe Objects) are, for th8 public ben8fil. lo preserve and protect public health in particular but not exclusively by.. advancing education in the science and praclical d8velopment ol cyhihalmology and alli8d subjects., a. promoting scientiflc r8sèareh relating to ophthalmdo9y and allied subieets by providing a platform lor presèntation and dissèmination ol such feseard) and by the provision ol grants and bursaries in support of such re￿arCh. Activities Slgnlfleant actlvltl•s The 2024 Congress was 898in 3uccessfulty heKJ in-person in Oxlord with attendances 88 expected and scientific a¢tivits'es 8t tho usual high standard. Publle b•n•llt The trustees havè review8d the outeomès and 8ehi*vemènts of thè objèctivès ant1 èctivitiès for thè pèriod in order to ensure that they remain focused on charitable aims and continued to deliv&r benefits to the public. Wè h8v& compliad with th* duty undar thè Charibès Act 2011 to hav• duè r￿ard to public bènèfit guidancè publishad by the Commission. DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Achievemenis and perforniance Significant activities and achievements againsl obieclives Th8 107th Congres5 wa5 SUCC85sftJlly hekl in person in July 2024. Total gross income generated by th8 Organisati￿ in 2024 and principally relating to that Congress amounted to £202,296. That cornpares to £112,061 in the 2023 financial y88r, on the face of it a ris8 of £90,235. 2024 was th8 rirst year th8 congress sold exhibib.on space at th8 meeting which ￿r￿unts for £58,244 of th8 Incx)m8 g8nerated and therefore a substantial proportion ol Ihe rise in income. Expen5esloverheads incurred in relabon to 2024 can be categoriseLI as.. Direcl activities related to the o)nference iotaling £178.05212023'. £115.1141. That 2024 figure indudes.. Venue hire and catering costs of £72.809 al the New Theatre. Oxford Town Hall and Hertford College12023', £31.6531'. St Annes and Worcester College accommodation costs associated with 2022 and 2023 expenditure due and speaker costs of £8.816 asswated wth the travel and speaker accommodation. Total expenditure of £56,123 12023., £22,124)., Smart Tuna 01 £20,75912023.' £22.794I'. Posters and printing ol £Nil12023.' £1.728}. Council m>ing gxpgn$&s lolaling £4.S¥J312023'. £5.1181 wimarity relating to travgl ¢￿ts and council me$ting room hlra and subsislenc8 costs. Finance . After accounting for 811 ol the above. the CIO generated a net 5urpluslprofit in 2024 in respect of Congre53 a¢livitie$ of £11,812 12023,. Defi¢iMoss ol £16,759). lfi addition to that surplus, thtr organisation 9oner8ted nel 98ins on th6 InvèstmÈnl portr¢￿10 Isae 'Finanual posit￿n") of £24,040 in the yèar12023.. £11,212) such that th8 overall nel in¢ome position of the company in 2024 was 8 surplus of £35,852 12023.. D¢fi¢it £5,547>. A$ a charit8bl• antity thara is no tax on profits gènèratèd. DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Financial review Flnanclal posltlon As these financial statements indicate, Ihe Charity has a sound finanoal base. One of the aims ol the Trustees is to secure the long-temi future of the Charity by carelul and prudent management ol its assets. As at 31 December 2024 the Charily held a number ol assets induding., The depreciated value ol the badge maker and Mastets d)ain1£5271', Prepayments in respect of the 2025 confèrènce1£24.7501 ré ExaminatiM S￿o￿5- C8sh in th8 BanklP8ypal of £42,048. In addition the CIO also held an inveslmentrlisled share FM)rtfolio managed by Cazenove. This portfolio had been in existence for many years and previously in the name of the unincorporaled entity before the trade. assets and liabilitie5 of that entity were transferred to the CIO in 2019. The value of that porlfolio at 31 December 2024 w8S £284,58012023.' £263,791). The organisation held liabilities totalrng £6.224 at that poinl. bw'ng Ihe am81 for 2024 accountancy fees of £2,100 and amount5 owe(J to Suppliers of £4,124. The result being that at the financial year end the r￿MpanY held net reserves of £353.181 Iversus £317,329 at 31 Decernber 2023 and £322.876 al 31 December 20221, 8 heallhy and solvent posrtK)n. The CIO will only commit to any material futu￿ expenses to Ihe exient Ihal they will be covered by future incornel Congre53 admission fees. To th8t exlent il is the ownion of the Irustses Ihat the existing reserves are sufficient lo cover any reduction in inccffiing resources in the foresee8ble future. Going ¢on¢em POST BALANCE SHEET EVENTS AND FUTURE DEVELOPMENTS We intend lo continue lo run the cio financially in a salisfaclory manner. holding appropriate reserves and investing in activities which will further our charrtable objectives. The 2024 Congress was held on 1- 3 July 2024. The 2025 Congress will be held from 7- 9 July 2025. Reseryes policy Wa aim lo hold r8sèrv8s almost èqual to that of thè anticipat￿ tol81 (x)st of holding futur8 Congrèssas and 8SSOCl8tad 8xp8nditurè 8nsuring that w• could conb.nue to m•èt our financial commitmanls and contrèctU81 obligations in the unlikely eventualily that we ￿ceiVed no funding from our memberslattendees for at least one entire finandal year. Structure, governanc• and managem•nt Govérning documént The chanty Is controlled by rts govgming do¢um6nt, thè Consb"tution of Th8 Oxford Ophthalmologi¢al Congross Charitabl8 Incorporatad Org8nis8tion and consblutes an incoryK)r8M d)arity. The organi88tion w85 registered as an irKlependenl tharity on 28 January 2019 Iregistered number 11817761 The Trustees who served during Ihe year and up to the date of signalure of the finanual 5taterTrents were.. C W Kinder M Stewart J Talks R Pilling M Parulekar Prof M S Sagoo S de Silva DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Org8nis8tiongl structur8 Organlsatlonal structure The first charity trustees were those as set cwjt in - and upon ratification ol - the Constitution ol The Oxford Ophlhalmological COng￿sS CIO. Generally. apart Irom the first charity trustees. the charity trustees shall be elected as charity trustees at Annual General Meetings and generally shall relire al the temiination of the terrns of office for which they are elected as charity trustees. However the charity twstees. after consulting Council (see belowl, may at any time decide to appoint 8 new charity truslee, whether in place of a charity trustee who has r8Slgll8d or has b88n rernoved or as an additional trustee. The CIO has in place a Council. comprising 22 indivmluals lor such other number as the charity trustees may decide). each of whom must b8 a member of the membership association referred to as the "members of the Oxford Ophthalmological Congress". Counril is responsible for advising Ihe board of charity trustees who m8n8ge the affairs of, and exercise 811 powers relaDng to, the CIO. Charity trustees must be mernb8rs of Gouncil (other than two additional charity InJsi885 wilh professional experience judged lo be useful lo the CIO, who shall sèrve for 8 tarm of thrè8 ￿arS and who shall not bè oificèrsl. The charity Iruslees and their tenns of office sh811 o)mprise- the Officers.. the Master. who shall serve lor one year. the Immen from, lh¢ CIO- receive any other financial benefit from the CIO.. unless the payment or benefit is permitted by specific sutpdauses ol the c0nstilul￿n. authorised by the court or the prior written consent ol the Charity Commission has been obtained. Furthermore the Constitution contains specific provisions generally prohibiling andlor restricting liaison with connected or related parties for both besl practice Govemanceloversighl and in order to ensure thal third party terms are always maintained. The Constitution does allow for reirnbursement of reaSona￿e Iravevrelated cosis, for example to Trustees as set out at Note 4 lo these financial slaiements. DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 The Trustees. report was approved by the Board ol Trustees. Parulekar Trustee 6 July 2025 DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO I report to the Trustees on my examination of the financAal statements of Th8 Oxford Ophthalmologic81 Congr88s CIO Ith8 Charity) for th8 year ended 31 D￿rn￿r 2024. R•sponslbllltl•s and basls ol r•port As the Trustees of the Charity you are responsible for the preparalion of the finan￿81 statements in accordance with the requirernents of the ch8rib.es Art 2011. I report in respect of my examinat￿ ol thè ChawiW$ finanual stalements carried tNJt under $edion 145 of the Charities Act 2011. In carrying out rny exarnination I hav8 followed the Oir8ctions giv8n by th8 Charity Comfflission under section 14515llbl ol the Chantses Aci 2011. Ind•pend•nt •xamlnerfs statem•nt Your attention is drawn to the fact that the charity h83 prep8red the financi81 statements in accordance with the r818vant V8rsion of the Statement of Recofflrnended PractlC8 applicable to rthariti85 preparing their financial statements in accordance with the Financial Reporting Slandard applicablè in thè UK and Republic ol Ireland IFRS 1021 in preference to the Accounting and Reporting by Charities". Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extsnl regulabons but has now been withdrawn. l understand that this has been done in order for the financial statements to provide a true and fair view in accordance with UK Generally Accepted Accounting Practs'ce. I have cornpleted my examination. l ojnfim that no matters have o)me lo my aitention in connectson with the ex8mination giving me cause to believe thal in any materi81 ￿specI.. accounting records w8r8 not kept in r&sp8Ct ol th8 Charity as r8qUif•d by s8ction 130 of tha Charities Act 2011. the financi81 slalernents do not accord wilh those record5,' or the financial statements do not comply with Ihe applicable requirements concerning the fom and content ol financial slalernenls set out in the Charilies (Accounts and Reports) Regulations 2008 other than any requirement that the financial statements give a Irue and fair view. wthich is r￿t a matter considered as part ol an independent examinalion. I have no concerns and have come 8tr0ss no olher matters in t))nn￿tIOn ¥￿th Ihe examination lo which attention should be drawn in this report in order to enable a proper underslanding of ¢he finanix81 statements lo be reached. 3529108EM844r Rob Ribchester FCA MA Flnchale Hous Belmont Business Park Durham DH1 1TW 6 July 2025 DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 DECEMBER 2024 Unrestricted funds 2024 Unrestricted nds 2023 Notes Incomg frorn: Donations and legaaes 202,296 112,061 Total Ineom• 202,296 112,061 Expendltur• on: Charitablè acts'vits'as 190,484 128,820 Total •xp•ndltur• 190,484 128,820 Nel gainsll105sesl on investments 24,040 11,212 N•t Incom•ll•xp•ndltur•l and mov•m•nt In lunds 35,852 15,5471 Reconclllatlon of funds: Fund balances at 1 January 2024 317,329 322,876 Fund balancès at 31 D•e•mb•r 2024 353,181 317,329 The stslemenl ol financi81 aclivths indudes all gain5 and losses reco3nised in the year. All income and expenditure derivo from ¢ontinuing 8ctsvities. DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO BALANCE SHEET AS AT31 DECEMBER 2024 2024 2023 Notes Fixed assets Tangible assets Inv85tm8nts 11 12 527 284,580 659 263,791 285,107 264,450 Current a¥￿ts D8blors Cash at bank and in hand 13 32.2 42.048 7.000 49.899 74,298 56,899 Cr8dltor8: amounts falllng du• wSthln one year 14 16.2241 14.0201 Not current a880ts 68.074 52,879 Total ass•ts 1088 curr•nt Ilabllltl•s 353,181 317,329 Th• fund8 01 th• Charlty Unrestricted funds 15 353,181 317,329 353,181 317,329 The financial statements were approved by the Trustees on 6 Juty 2025 M Parulekar Trustee DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Accounting policies Charlty Inforrnatlon The Oxford Ophthalmological COng￿$S CIO is a charity registered in England and Wales. The registered offic8 is Camerons Solicitors LLP. 70 Wimpole Streel. London. W1G 8AX. 1.1 Accounting convention The financial statements have been Prepared in accordance wlh Ihe Charitys governing document. the Charities Act 2011. FRS 102 Yhe Financial Reporting Standard applicable in the UK and Republic ol Ireland. and the Charities SORP "Accounting and Reporting by Charits'es.. Statement of Recommended Practice applicable to charities preparing their accounts in accordance wilh the Finanrial Reporting Standard pplicable in the UK and Republic of Ireland IFRS 1021" The Chaty is a publ￿ Benefit Entity 8s defined by FRS 102. Th8 Charfty has tak8n advantagè ol Ihè prowsions In thè SORP lor charities not to prèparè a statemènt ol cash flows. The financial statements hav8 departed from the Charities {A￿ntS and Reports) Regulations 2008 only to the extent required to provide a true and lair view. This departure has involved following the Statement of Recornrnended Praclice for chari¢￿s applying FRS 102 rather than the version of the Statement ol Recornrnended Pr8ctice which is refwred to in the Regulations bul which has since been wthdrawn. The fin8n¢i81 Slaitrments are prepared in sterling, vthi¢h is thtr lun¢bonal currency of the Charity. Monetary amounts in thes& fin¥n¢ial $tslem¥nts a￿ rounded to th& n¥aresl £. The financial slalemènts have been prepar8d und8r the historical cost convantlon. Tha principal accountlng policies adopted are s8t out below. 1.2 Golng concern Al the lirne of approvlng the finan￿al stslemenis, Ihe Twstees have a reasonable expectation tt)at the Charlty ha5 adequate re$our¢ss to continue in oper8tion81 &XiSlence for the foreseeable future. Thus the Trustees continua to adopt thè 9tsing conc*m ba*s of accounb.ng in prèparing thé financial sialèmants. 1.3 Ch¥ritsble funds Unrestricted funds a￿ available for use at the discretion of ihe Trnstees in furtherance of their charitable objectives. RaStriCt￿ funds ara subj8Ct to specffic conditions by donors or grantcws as lo how th&y may ba us6d. The purposes and uses of the reslricted funds are set out in the notes lo the financial statements. Endowment lund5 are subject to specffic o)ndition5 by donrys that Ihe capitsl must be mainl8ined by the Charity. 1.4 Income Income is recognised when the Charity is legally entilled to it after any perforniance conditions have been met, the amounts can be measured reliably. and it is probable that income will be ￿CeIved. Cash donations are recognised on receipt. Other donations are recognised once the Charity has been n(>trfied ol the donation, unless perfomiance condib.ons requi￿ deferral of the amount. Income tax recoverable in relation to donations received under GIftA￿ ordeeds ol covenant is recognised at the time ol the donation. Legacies are recognised on receipt or otherwise rf the Chawity has been notified of an impending distribution, the amount is known, and re￿Ipl is eycted. If the arnount is nol known, the legaw is treated as a contingent asset. DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Aeeounting policlès IContlnu8dl 1.5 Expendlture Expenditure is rectMJnised onc8 there is a 18gal (x construclive obligation to transfer ècon(>mic benèfit to a third party, il is probable thal a transfer ol economic benefits will be required in settlement, and the amount ol the obligation can be measured reliably. Expenditure is classrfied by actiwty. The costs of each activty are made up of the total of direct costs and shared costs, including support costs invofved in undertaknng each acbvity. Direct costs attributable to a single activity are allocated direcuy to that activity. Shared costs which contribute to more than one activity and support costs which are not attribut8ble to a single activity ar8 apportion8d b8tW88n those activit185 on a b8SIS on5i5t8nt with the use of resources. Central stall costs are alkKaled on the basis of time sp8nl, and dèpreciation charges a￿ allocaleil on th* porti￿ ol the asset's us¢. 1.6 Tanglbl• flx•d assets Tangible fixed assets are Inilially measured at cost and Subs8q￿n￿Y measured at ujst or valuation, net ol depreciation and any Impalm￿nI losses. D8prècialion is rècognis8¢J so a$ lo wiitè off Ihè cost or Valuati￿ ol assèts thair rèsidual valuès ovar thalr usolul liv&s On the followin9 bas$s.' Plant and equipment 20% on reduclng balance The gain or loss arising on the disFM)sal of an assel is detemiined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the ststement ol financial activits'es. 1.7 Flx•d a88•1 Invéstm•nts Fixed asset investrnents are initsally measured ai trnn$8dion rite exduding transaction ¢o$t$, and ara subsèquently m88sur8d 81 fair valuè at each réporting dale. Changes in fair value arè r•¢ognisèd in nèl in¢omellexpen(Jiturel for the yeai. fransacuon costs are expensed as sncurrei1. 1.8 Impalmient of fixed assets At each reporting end date, the Charrty ffjviews the carying amounts of rts tangible assets to detarmlne whether there is any indication that th)se assets have suffered an impaiment loss. If any such indication exists, the recoverabb amount ol the asset is estimated in order lo deterniine the extent ol the impairment loss lil any). 1.9 Cash and cash •qui¥al•nts Cash and cash equivalents include cash in hand, deposits held at ¢811 with banks, other short-term liquid inveslm8nt5 Wlth original maluritie5 01 Ihree months or less, and b8nk overdralts. 88nk overdr8fts are shown wrthin borrowings in current liab'lities. 1.10 Financial instrument5 The Charity has elecled to apply Ihe provisions ol Section 11 'Basic Financial Instrumenis, and Section 12 'Olher Financial Instrurnents Issue5. of FRS 102 to all of its financial instrurnents. Financial instrurnents ar8 recogni5ed in th8 Chartys balar￿e sheet when the Chartty b8COtll8S Party to th8 contractual provisions of the instrument. Finanaal assets and liabililies are offset. with the net an￿￿￿t$ presented in ihe financial statements, when there is a legally enforceable right lo sel off Ihe recognised amounts and Ihere is an intention to settle on a nel basis or to realise the asset and semle Ihe lia￿'l1ty simultaneously. 10- DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Aeeounting policiès IContinu8dl Baslc flnanclalassets 8asic financial assets, which indud8 d8btors and cash and bank balancès. ar8 initially mèasured 8t transaction price incIL￿ing transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a finanan9 transaction. where the transaction is measured at the present value of Ihe lulure re￿IPtS discounted at a Ma￿et rate of inlerest. FinancAal assets classified as receivable within one year are nol amorb'sed. Basic fin•nci•l li•biliti•$ Basic financial liabilities, Induding crèditors and bank loans are initially fecognised at transaction price unless the arrangement constsluies a financing transaction. where Ihe debt instrument is measured at the p￿sent value of the future payments discounted al a market rale of inte￿$t. Financial liabilities classified as payable within one year are r￿t amortised. Debt inslrurnents are subseqvenlly carried at amorlised cost, using Ihe effective interest rate method. Tr8d8 crèditors are obligations lo pay lor goods or swvices that havè bèèn acquirèd in thè ordinary cours8 01 operations from suppliers. Amounts payable are dassffied as current liabilities il payment is due within one year or less. 11 not, they are presented as non-ojrrenl liabilities. Tra¢Jè credilors are recognis*d initially 81 transaction prlc• and subsequ•ntty measured 8t anKrftised cost using the effectlve Intèrasl m8thod. D•r8cognltlon of Ilnanclal Ilabllltl•s Financial liabiliti¢$ aw d&r•¢¢*3nis¢d when th& Charitls ¢ontra¢tual oLqigations expire ¢y are dls¢harged or cancèllsd. 1.11 Employ•• b•n•ffts The cost of any unused holiday entilltrmeni is re¢tsJni$8(l in the period in which the employoe's servictrs ara rsceiv8d. T&mination bengfits arè r￿gnI￿d immèdiai&ly as an expense when the Charity 1$ dgmonstrably committgd to tèrminata tha employmènt of an &mp*)y*è or to provide tèmination banèfits. Crlllcal accountlng •stlmat•8 and ludg•m•nts In the application of the Charity's accounting poliaes. Ihe Trustees a￿ ￿qUired to make judgements, eslimates and assumptions abw¢ the carying amounl of assets and liabilitie5 that a￿ not readily apparent frorn other sources. The estimates and associated assumptions are based on historical experience and other factors that ale conSKlered lo b8 relevanl. Actual re5uIt5 may drffer frorn th8se 8sb"tn8tes. The esbmates and underfying assumptions are rewewed on an ongoing basis. Rèvisions tts accounting estsrnates a￿ ￿COgnised In the period in which the estimate is revised where the revision affects only that period. or in the ￿ri¢)d of the ￿￿slon and ftrture periods Whe￿ the reViS￿n affects both current and future periods. 11 DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Income from donations and legacies Unre5trfct funds 2024 Unre5trlcted nds 2023 Donations Attendance, accommodation and annual dinner 100 202,196 10,000 102,061 202,296 112,061 Exp•ndltur¢ on ¢harltabl• aetlvltl•$ Charltabl• activltles 2024 CharFtabla actlvlties 2023 DITO¢t co•t• Depreciation and impairnient V$nu& & Postèr hir8 College accommodation and dinner Matarial dèvabpmènt. assistant and me&tWlg costs Printing. postsge and stationery Audiovisual, onlinè suppc*t Insurance 132 72,809 56,123 27,971 558 31,653 22,124 35,680 1,728 22,794 577 20,759 258 178,052 115,114 Share of support •nd govem•n¢e c￿1¥ {¥eg note 51 Support 12,432 13,706 190,484 128,820 Analysls by fund Unrestricted funds 190,484 128,820 Support costs allocated to aclivitl 2024 2023 Council m88ting exp8ns8S Finan￿ costs Govsmancè costs 4,￿3 5.429 2,100 5,118 6,368 2,220 12,432 13,706 Analysod bètwo•n: Charitable activities 12.432 13.706 12- DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Net rnovement in funds 2024 2023 Th8 net Fnov8in8nt in lunds is stat8d 8ft8r Chargin￿{￿e￿I￿ngl'. Fees payable lor the independent examination of the charity's finanual statements Depre¢i8tion of owr￿1 tangible fixed assets 2,100 132 2,220 558 TrustO•S None of the Trustees lor any persC￿S c£Jnn8cled wilh theml recEived any remuneration or benefrts from the Charity during ¢he year. Employ99• The averagg monthly number ol employees durfng lh& year wa$.. 2024 Nurnbgr 2023 Number Total There Wtr￿ no employees vthose annual remurwation w8$ mtye than £60,0fy). R•mun•ratlon of k•y manag•mont p&T￿nn•1 The remuneration of key management personnel was as follows.. Galn8 and1089o8 on Investm•nts Unrg$trlcted Unrgstrl￿?d funds funds 2024 2023 Gainslllossesl arising on.. Revaluatson ol inves¢ments 24,040 11,212 10 Taxation The charity is exempl from laxation on its aclivii*s because all its income is applied for charitable purposes. 13- DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 11 Tangible fixed asset$ Plant and equipment Cost At 1 JanLJ8ry 2024 3,031 At 31 December 2024 3,031 Depr8eiatJon and Impairmont At 1 January 2024 D8prèciation charge(l in Ihè yèar 2,372 132 At 31 December 2024 2,504 Carylng amount Al 31 Oe¢emb&r 2024 527 Al 31 Oe¢ember 2023 659 12 Flxed a8S•t Investm•nts Llst•d Inv•stments Cost or valuallon Al 1 January 2024 valuati￿ chang8S 263,791 20,789 At 31 De￿mber 2024 284,580 Carrylng amount At 31 0•c6mbèr 2024 284,580 At 31 Oecemb&r 2023 263,791 13 Oebtor 2024 2023 Amounts falling due ￿thin one year= Trade debtors Prepayrnents and accrued income 7,500 24.750 7,000 32,250 7,000 14- DoGusign Envelope ID". 198F6FAA-65884858-9B8WB6FFC7101D THE OXFORD OPHTHALMOLOGICAL CONGRESS CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 14 Creditors= amounts falling due within one year 2024 2023 Trade creditors Accruals and deferred income 4,124 2,100 4,020 6,224 4,020 15 Unr•strlct•d funds The unrestricted funds of the charity comprise Ihe unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated fund5 which have been set aside (xrt of unrestrKted fvnds by the trustees for specific purposes. At 1 January 21124 Ineornlng sourc•s Resourte$ •X￿ftd Galn¥ and 10s8•S At31 Dèe•mbèr 2024 General funds 317.329 202,296 1190,4841 24,040 353,181 Provlou8 y•ar'. At 1 January 2023 Incomlng r•sourc•s Resources •xp•nded Galns and 108808 At31 Decomber 2023 General funds 322.676 112,C61 1128,8201 11,212 317,329 16 R•latod party transactlons There were no disdosable rdated party transactions dvring the year12023- nonel. 15-